Compare CODI & CTKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CODI | CTKB |
|---|---|---|
| Founded | 2005 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Home Furnishings | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 480.8M | 541.1M |
| IPO Year | N/A | 2021 |
| Metric | CODI | CTKB |
|---|---|---|
| Price | $10.36 | $4.07 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 2 | 4 |
| Target Price | ★ $9.25 | $5.63 |
| AVG Volume (30 Days) | 970.0K | ★ 2.0M |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $193,015,000.00 |
| Revenue This Year | N/A | $5.42 |
| Revenue Next Year | $5.25 | $7.03 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 17.67 |
| 52 Week Low | $4.58 | $3.09 |
| 52 Week High | $12.64 | $6.18 |
| Indicator | CODI | CTKB |
|---|---|---|
| Relative Strength Index (RSI) | 43.69 | 50.64 |
| Support Level | $9.60 | $3.71 |
| Resistance Level | $11.11 | $4.17 |
| Average True Range (ATR) | 0.46 | 0.23 |
| MACD | -0.06 | 0.00 |
| Stochastic Oscillator | 50.50 | 50.00 |
Compass Diversified Holdings is a diversified business conglomerate based in the United States having two groups: branded consumer business and industrial business. Branded consumer businesses are characterized as those businesses that capitalize on a valuable brand name in their respective market sector. It includes 5.11, Ergobaby, Liberty Safe, and Velocity Outdoor. Industrial businesses are characterized as those businesses that focus on manufacturing and selling particular products and industrial services within a specific market sector. The company has operations in the United States, Canada, Europe, Asia Pacific, and other International areas.
Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of research and clinical tools with its novel technical approach of leveraging the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its patented FSP technology optimizes sensitivity and accuracy through its optical and electronic designs that utilize an inventive method of light detection and distribution to a specifically selected number and type of detectors. Its FSP cell analyzers, the Cytek Aurora, Northern Lights, and Cytek Aurora Evo systems, deliver high-resolution, high-content and high-sensitivity cell analysis and address the inherent limitations of other technologies.